DNA vaccination for HIV

Nature Medicine

Volumn 3, Issue 5, 1997, Pages 501-502

  Kennedy, Ronald C ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030940772     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0597-501     Document Type: Short Survey

References (11)

1. Boyer, J.D. et al. Protection from high dose heterologous HIV-1 challenge in chimpanzees by DNA vaccination. Nature Med. 3, 526-532 (1997).
2. Cohen, J. Naked DNA points the way to vaccines. Science 259, 1691-1692 (1993).
3. McDonnell, W.M. & Askari, F.K. DNA vaccines. N. Engl. J. Med. 334, 42-45 (1996).
4. Baltimore, D. Lessons from people with nonprogressive HIV infection. N. Engl. J. Med. 332, 259-260 (1995).
5. Haynes, B.F., Pantaleo, G. & Fauci, A.S. Toward an understanding of the correlates of protective immunity to HIV infection. Science 271, 324-328 (1996).
6. Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D.D. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332, 201-208 (1995).
7. Rinaldo, C. et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1 ) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1 infected long-term non-progressors. J. Virol. 69, 5838-5842 (1995).
8. Fouts, T.R. et al. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71, 2779-2785 (1997).
9. Wang, B. et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156-4160 (1993).
10. Wang, B. et al. Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation. Virology 211, 102-112 (1995).
11. Lu, S. et al. Simian immunodeficiency virus DNA vaccine trial in macaques. J. Virol. 70, 3978-3991 (1996).